Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 2,365 | 1,589 | 1,616 | 1,159 | 482 |
| Gross Profit | 2,365 | 1,589 | 1,616 | 1,159 | 482 |
| Operating Expenses | 19,626 | 15,131 | 15,106 | 12,062 | 6,734 |
| Operating Income | -17,261 | -13,542 | -13,490 | -10,903 | -6,252 |
| Other Income | 373 | 132 | 74 | 137 | 46 |
| Pre-tax Income | -16,888 | -13,410 | -13,416 | -10,766 | -6,206 |
| Net Income Continuous | -16,888 | -13,410 | -13,416 | -10,766 | -6,206 |
| Net Income | $-16,888 | $-13,410 | $-13,416 | $-10,766 | $-6,206 |
| EPS Basic Total Ops | -0.41 | -0.32 | 1.55 | -0.26 | -0.62 |
| EPS Basic Continuous Ops | -0.41 | -0.32 | 1.55 | -0.26 | -0.62 |
| EPS Diluted Total Ops | -0.41 | -0.32 | 1.55 | -0.26 | -0.62 |
| EPS Diluted Continuous Ops | -0.41 | -0.32 | 1.55 | -0.26 | -0.62 |
| EBITDA(a) | $-17,252 | $-13,485 | $-13,484 | $-10,955 | $-6,274 |